Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in Indian patients with heart failure with preserved ejection fraction – “ARNI-PRESERVED” study

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in Indian patients with heart failure with preserved ejection fraction – “ARNI-PRESERVED” study

Background: The goal of this study is to look at the safety and efficacy of angiotensin receptor-neprilysin inhibitors (ARNI) (valsartan/sacubitril), a combination of angiotensin II receptor blocker and neprilysin inhibitor ARNI, in patients with heart failure with preserved ejection fraction (HFpEF...

Full description

Bibliographic Details
Main Authors: Pankaj Jariwala, Arshad Punjani, Harikishan Boorugu, Dilip Babu Madhawar, Kartik Jadhav
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Heart India
Subjects:
angiotensin receptor-neprilysin inhibitor
heart failure with preserved ejection fraction
sacubitril/valsartan
Online Access:http://www.heartindia.net/article.asp?issn=2321-449x;year=2021;volume=9;issue=3;spage=179;epage=183;aulast=Jariwala

Internet

http://www.heartindia.net/article.asp?issn=2321-449x;year=2021;volume=9;issue=3;spage=179;epage=183;aulast=Jariwala

Similar Items